Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03458897 · ClinicalTrials.gov registry record · NA
Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
A NA study of Sickle Cell Disease, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03458897: Completed NA study of Sickle Cell Disease, sponsored by University of Michigan.
NCT03458897 is a NA study of Sickle Cell Disease that has completed, run by University of Michigan. The registered enrollment target is 7 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03458897, a NA study of Sickle Cell Disease, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this research is to determine if it is feasible to perform serial magnetic resonance imaging (MRI) to evaluate the amount of bone marrow cells (also called cellularity) and iron stores before and after bone marrow transplantation for severe sickle cell disease.
Primary Outcome
Feasibility will be measured by the number of subjects who undergo at least 2 of 4 scheduled functional MRI's
Conditions Studied
Interventions
- DIAGNOSTIC_TEST serial functional magnetic resonance imaging (MRI)
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-05-03 |
| Est. Completion | 2020-09-01 |
| Phase | NA |
What the finished NCT03458897 record still lists
NCT03458897 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which serial functional magnetic resonance imaging (MRI) is the first listed.
NCT03458897 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT03458897 about?
NCT03458897 is a clinical study titled "Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant". The primary purpose of this research is to determine if it is feasible to perform serial magnetic resonance imaging (MRI) to evaluate the amount of bone marrow cells (also called cellularity) and iron stores before and after bone marrow transplantation for severe sickle cell disease.
What is the current status of trial NCT03458897?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-05-03. Estimated completion is 2020-09-01.
What conditions does trial NCT03458897 study?
This clinical trial studies the following conditions: Sickle Cell Disease.
What interventions are being tested in trial NCT03458897?
The interventions under investigation include: serial functional magnetic resonance imaging (MRI) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03458897?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03458897 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03458897's enrollment target sits among peer trials
7 202nd of 213 higher than 10 of 213 other Sickle Cell Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI